Sugiyama E, Cantagrel A, Reno T, Stafford-Brady F, Yeh E T, Bonventre J V
Medical Services, Massachusetts General Hospital, Harvard Medical School, Boston 02114.
Cell Immunol. 1990 Oct 15;130(2):271-80. doi: 10.1016/0008-8749(90)90270-2.
Ly-6A is a glycosyl-phosphatidylinositol (GPI)-anchored molecule that participates in murine T cell activation. Activation of T cell hybridomas with anti-Ly-6A monoclonal antibody (mAb) leads to production of interleukin-2 (IL-2), but also to a paradoxical growth inhibition, which was used to select for signaling mutants. Fifteen subclones derived from two independent mutageneses and anti-Ly-6A selection were characterized. Thirteen subclones responded poorly or not at all to soluble anti-Ly-6A mAb. Although the selective pressure was exerted through Ly-6A, only one mutant did not express the Ly-6A antigen. Interestingly, 10 of the 15 subclones expressed either nondetectable or a very low level of T cell receptor/CD3 complex (TCR/CD3). Preferential expansion of TCR/CD3 expression mutants following anti-Ly-6A selection further established functional linkage between Ly-6A and TCR/CD3 complex. The mechanism of the functional coupling was investigated by analyzing the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2), one of the early events in T cell activation. We showed that PIP2 was not hydrolyzed in response to anti-Ly-6A in TCR/CD3-negative mutants. Aluminum fluoride, which activates G protein directly, did induce PIP2 hydrolysis in these cells. These data suggest that activation signals originated from Ly-6A must be transmitted first to TCR/CD3 complex, which then couples to the G protein/phospholipase C system. A similar requirement also applies to the Thy-1 protein and lectin receptors. Thus, the TCR/CD3 complex plays a central role in the integration and transmission of activation signals that originated from several T cell surface molecules.
Ly-6A是一种糖基磷脂酰肌醇(GPI)锚定分子,参与小鼠T细胞活化。用抗Ly-6A单克隆抗体(mAb)激活T细胞杂交瘤会导致白细胞介素-2(IL-2)的产生,但也会导致矛盾的生长抑制,这被用于筛选信号突变体。对来自两次独立诱变和抗Ly-6A筛选的15个亚克隆进行了表征。13个亚克隆对可溶性抗Ly-6A mAb反应不佳或完全无反应。尽管选择压力是通过Ly-6A施加的,但只有一个突变体不表达Ly-6A抗原。有趣的是,15个亚克隆中有10个表达不可检测或极低水平的T细胞受体/CD3复合物(TCR/CD3)。抗Ly-6A选择后TCR/CD3表达突变体的优先扩增进一步确立了Ly-6A与TCR/CD3复合物之间的功能联系。通过分析磷脂酰肌醇4,5-二磷酸(PIP2)的水解来研究功能偶联的机制,PIP2水解是T细胞活化的早期事件之一。我们发现,在TCR/CD3阴性突变体中,抗Ly-6A不会诱导PIP2水解。直接激活G蛋白的氟化铝确实能在这些细胞中诱导PIP2水解。这些数据表明,源自Ly-6A的激活信号必须首先传递到TCR/CD3复合物,然后该复合物再与G蛋白/磷脂酶C系统偶联。类似的要求也适用于Thy-1蛋白和凝集素受体。因此,TCR/CD3复合物在整合和传递源自多个T细胞表面分子的激活信号中起核心作用。